ANHUI ANKE BIOTECHNOLOGY (GROUP)CO.,LTD. — Investor Relations & Filings
Anhui Anke Biotechnology (Group) Co., Ltd. is a high-tech enterprise specializing in the research, development, production, and commercialization of biopharmaceutical products. The company focuses on genetic engineering, cell therapy, and precision medicine. Its core product portfolio includes recombinant human growth hormone (rhGH) marketed under the brand Ansomone, and recombinant human interferon alpha-2b known as Anterferon. Anke Bio also develops diagnostic reagents, including biochemical and molecular diagnostic kits, and provides services in the fields of oncology and reproductive health. The company maintains a strong emphasis on innovation through its dedicated R&D centers, aiming to provide advanced therapeutic solutions for growth disorders, viral infections, and various cancers. Its operations span the entire value chain from basic research to clinical application and market distribution.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 防范控股股东及关联方占用公司资金制度（2025年11月） | 2025-11-25 | Chinese | |
| 委托理财管理制度（2025年11月） | 2025-11-25 | Chinese | |
| 投资者关系管理制度（2025年11月） | 2025-11-25 | Chinese | |
| 信息披露暂缓与豁免管理制度（2025年11月） | 2025-11-25 | Chinese | |
| 重大信息内部报告制度（2025年11月） | 2025-11-25 | Chinese | |
| 审计委员会工作细则（2025年11月） | 2025-11-25 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 35333325 | 防范控股股东及关联方占用公司资金制度（2025年11月） | 2025-11-25 | Chinese | ||
| 35333308 | 委托理财管理制度（2025年11月） | 2025-11-25 | Chinese | ||
| 35333304 | 投资者关系管理制度（2025年11月） | 2025-11-25 | Chinese | ||
| 35333293 | 信息披露暂缓与豁免管理制度（2025年11月） | 2025-11-25 | Chinese | ||
| 35333282 | 重大信息内部报告制度（2025年11月） | 2025-11-25 | Chinese | ||
| 35333278 | 审计委员会工作细则（2025年11月） | 2025-11-25 | Chinese | ||
| 35333270 | 安徽天禾律师事务所关于安徽安科生物工程（集团）股份有限公司第三期限制性股票激励计划首次授予部分及预留授予部分限制性股票解除限售条件成就情况及回购注销部分限制性股票相关事项之法律意见书 | 2025-11-25 | Chinese | ||
| 35333255 | 第八届董事会薪酬与考核委员会关于公司第三期限制性股票激励计划相关事项的核查意见 | 2025-11-25 | Chinese | ||
| 35333247 | 独立董事候选人声明与承诺（陈飞虎） | 2025-11-25 | Chinese | ||
| 35333234 | 独立董事提名人声明与承诺（陈飞虎） | 2025-11-25 | Chinese | ||
| 35333220 | 独立董事提名人声明与承诺（耿小平） | 2025-11-25 | Chinese | ||
| 35333209 | 关于高级管理人员减持计划实施完成的公告 | 2025-11-17 | Chinese | ||
| 35333200 | 关于第八届监事会第二十一次会议决议的公告 | 2025-11-11 | Chinese | ||
| 35333199 | 关于向博生吉医药科技（苏州）有限公司增资暨关联交易的公告 | 2025-11-11 | Chinese | ||
| 35333195 | 关于签署PA3-17注射液产品独家代理框架协议暨关联交易的公告 | 2025-11-11 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
ANHUI ANKE BIOTECHNOLOGY (GROUP)CO.,LTD. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/55035/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=55035 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=55035 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=55035 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 55035}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ANHUI ANKE BIOTECHNOLOGY (GROUP)CO.,LTD. (id: 55035)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.